HHS delays implementation of drug price-gouging rule until July

HHS delayed implementation of an ACA regulation Thursday that would punish drug companies for price gouging, according to The Hill.

Advertisement

The rule would punish companies for knowingly overcharging customers by issuing $5,000 fines for each instance of price-gouging. It is the fourth time the Trump administration has delayed the rule, which is now set to begin in July.

“HHS continues to believe that the delay of the effective date provides regulated entities sufficient time to implement the requirements of the rule, as well as allowing a more deliberate process of considering alternative and supplemental regulatory provisions, and to allow for sufficient time for additional rule-making,” an HHS spokesman told reporters, according to The Hill.

More Articles on Leadership:

Graham-Cassidy sponsors believe bill can pass with proper process
House Dems call on HHS to shorten HealthCare.gov shutdowns during enrollment period
Dr. Anthony Tersigni: Integrated care can help make a difference for the opioid epidemic

At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.

Advertisement

Next Up in Leadership & Management

  • GLP-1s Are Not the End of Bariatric Surgery — They Are Reinventing Obesity Care The rise of GLP-1 medications is…

  • AdventHealth’s operating margin climbed to 13.4%, while UPMC swung to an $18.3 million operating loss. Here is a snapshot of…

Advertisement

Comments are closed.